Inhibition of Neutrophil Activity Improves Cardiac Function After Cardiopulmonary Bypass
The arterial in line application of the leukocyte inhibition module (LIM) in the cardiopulmonary bypass (CPB) limits overshooting leukocyte activity during cardiac surgery.